These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2657908)

  • 1. Multiple cytotoxic effector cells are induced by infection with the human immunodeficiency virus.
    Rivière Y; Tanneau-Salvadori F; Regnault A; Lopez O; Sansonetti P; Guy B; Kieny MP; Fournel JJ; Montagnier L
    Res Immunol; 1989 Jan; 140(1):110-5; discussion 121. PubMed ID: 2657908
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-gag-specific cytotoxic T lymphocytes.
    Nixon DF; McMichael AJ
    Res Immunol; 1989 Jan; 140(1):107-10; discussion 121. PubMed ID: 2657907
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of vaccinia virus vectors for development of AIDS vaccines.
    Moss B
    AIDS; 1988; 2 Suppl 1():S103-5. PubMed ID: 3147660
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxic T-cell recognition of HIV proteins and peptides.
    Nixon DF; McMichael AJ
    AIDS; 1991 Sep; 5(9):1049-59. PubMed ID: 1718319
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.
    Rowland-Jones S; Sutton J; Ariyoshi K; Dong T; Gotch F; McAdam S; Whitby D; Sabally S; Gallimore A; Corrah T
    Nat Med; 1995 Jan; 1(1):59-64. PubMed ID: 7584954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of HLA in HIV-1 infection].
    Takiguchi M
    Uirusu; 2000 Jun; 50(1):47-55. PubMed ID: 10998978
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones.
    Sethi KK; Näher H; Stroehmann I
    Nature; 1988 Sep; 335(6186):178-81. PubMed ID: 2842692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV and AIDS.
    Laman JD
    Science; 1993 Jun; 260(5115):1707-8. PubMed ID: 8511573
    [No Abstract]   [Full Text] [Related]  

  • 9. Human trials of experimental AIDS vaccines: recombinant envelope proteins.
    Snart RS
    AIDS; 1988; 2 Suppl 1():S107-11. PubMed ID: 2906544
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts.
    Goudsmit J
    AIDS; 1988; 2 Suppl 1():S41-5. PubMed ID: 2465771
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunopathogenesis and immunotherapy in AIDS virus infections.
    Letvin NL; Walker BD
    Nat Med; 2003 Jul; 9(7):861-6. PubMed ID: 12835706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS pathogenesis: a finite immune response to blame?
    Miedema F; Klein MR
    Science; 1996 Apr; 272(5261):505-6. PubMed ID: 8614796
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular immune response to viral peptides in patients exposed to HIV.
    Ahearne PM; Matthews TJ; Lyerly HK; White GC; Bolognesi DP; Weinhold KJ
    AIDS Res Hum Retroviruses; 1988 Aug; 4(4):259-67. PubMed ID: 2462895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects.
    Goh WC; Markee J; Akridge RE; Meldorf M; Musey L; Karchmer T; Krone M; Collier A; Corey L; Emerman M; McElrath MJ
    J Infect Dis; 1999 Mar; 179(3):548-57. PubMed ID: 9952360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children.
    Luzuriaga K; Koup RA; Pikora CA; Brettler DB; Sullivan JL
    J Pediatr; 1991 Aug; 119(2):230-6. PubMed ID: 1907319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination.
    Plata F; Dadaglio G; Chenciner N; Hoffenbach A; Wain-Hobson S; Michel F; Langlade-Demoyen P
    Immunodefic Rev; 1989; 1(3):227-46. PubMed ID: 2698642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular immune response to the human immunodeficiency virus.
    Rivière Y
    Curr Opin Immunol; 1989-1990 Feb; 2(3):424-7. PubMed ID: 2576771
    [No Abstract]   [Full Text] [Related]  

  • 19. Why can't cytotoxic T cells handle HIV?
    Bevan MJ; Braciale TJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5765-7. PubMed ID: 7597026
    [No Abstract]   [Full Text] [Related]  

  • 20. Proliferative T-cell response to HIV envelope glycoprotein in immunized and infected primates and human beings.
    Krohn K; Ranki A; Lusso P; Moss B; Ashorn P; Arthur LO; Putney SD; Gallo RC
    J Med Primatol; 1989; 18(3-4):363-9. PubMed ID: 2547967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.